1. Home
  2. KLXE vs GBIO Comparison

KLXE vs GBIO Comparison

Compare KLXE & GBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KLXE
  • GBIO
  • Stock Information
  • Founded
  • KLXE 2018
  • GBIO 2016
  • Country
  • KLXE United States
  • GBIO United States
  • Employees
  • KLXE N/A
  • GBIO N/A
  • Industry
  • KLXE Oilfield Services/Equipment
  • GBIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • KLXE Energy
  • GBIO Health Care
  • Exchange
  • KLXE Nasdaq
  • GBIO Nasdaq
  • Market Cap
  • KLXE 35.8M
  • GBIO 29.2M
  • IPO Year
  • KLXE N/A
  • GBIO 2020
  • Fundamental
  • Price
  • KLXE $1.95
  • GBIO $0.39
  • Analyst Decision
  • KLXE Hold
  • GBIO Strong Buy
  • Analyst Count
  • KLXE 1
  • GBIO 4
  • Target Price
  • KLXE $4.50
  • GBIO $7.33
  • AVG Volume (30 Days)
  • KLXE 282.5K
  • GBIO 1.1M
  • Earning Date
  • KLXE 08-06-2025
  • GBIO 08-06-2025
  • Dividend Yield
  • KLXE N/A
  • GBIO N/A
  • EPS Growth
  • KLXE N/A
  • GBIO N/A
  • EPS
  • KLXE N/A
  • GBIO N/A
  • Revenue
  • KLXE $688,600,000.00
  • GBIO $24,556,000.00
  • Revenue This Year
  • KLXE N/A
  • GBIO N/A
  • Revenue Next Year
  • KLXE $3.97
  • GBIO N/A
  • P/E Ratio
  • KLXE N/A
  • GBIO N/A
  • Revenue Growth
  • KLXE N/A
  • GBIO 146.47
  • 52 Week Low
  • KLXE $1.51
  • GBIO $0.30
  • 52 Week High
  • KLXE $7.66
  • GBIO $3.65
  • Technical
  • Relative Strength Index (RSI)
  • KLXE 46.16
  • GBIO 52.02
  • Support Level
  • KLXE $1.85
  • GBIO $0.32
  • Resistance Level
  • KLXE $2.02
  • GBIO $0.36
  • Average True Range (ATR)
  • KLXE 0.18
  • GBIO 0.03
  • MACD
  • KLXE -0.02
  • GBIO 0.00
  • Stochastic Oscillator
  • KLXE 13.48
  • GBIO 81.00

About KLXE KLX Energy Services Holdings Inc.

KLX Energy Services Holdings Inc is a provider of completion, intervention and production services and products to the onshore oil and gas producing regions of the United States. It serves the companies engaged in the exploration and development of onshore conventional and unconventional oil and natural gas reserves. Its products and services offerings include surface facilities and equipment, pressure control services, wireline services, fishing services, and engineered products. The company's segments include Southwest; Rocky Mountains and Northeast/Mid-Con region. It derives maximum revenue from Northeast/Mid-Con region.

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

Share on Social Networks: